VOR BIOPHARMA INC.
17.60%
1,204,442
1817229
929033207
Oct 14, 2025
Oct 17, 2025, 06:36 PM
Reporting Persons (2)
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Reprogrammed Interchange LLC | Other | 17.60% | 1,204,442 | 0 | 1,204,442 |
| Reid Hoffman | Individual | 17.60% | 1,204,442 | 0 | 1,204,442 |
Disclosure Items (5)
Common Stock, par value $.0001 per share
VOR BIOPHARMA INC.
100 Cambridgepark Drive, Suite 101, Cambridge, MA, 02140
Not applicable.
The information contained in rows 7, 8, 9, 10, 11 and 13 on each of the cover pages of this Amendment No. 8 to the Schedule 13D, and the information set forth or incorporated in Items 2, 3, 4, 6 and 7, is incorporated by reference in its entirety into this Item 5.
Regarding the number of shares as to which such person has: (i) sole power to vote or to direct the vote: See line 7 of cover sheets, (ii) shared power to vote or to direct the vote: See line 8 of cover sheets, (iii) sole power to dispose or to direct the disposition: See line 9 of cover sheets, and (iv) shared power to dispose or to direct the disposition: See line 10 of cover sheets.
During the past 60 days, Reprogrammed Interchange LLC sold the following shares of Vor Biopharma Inc. in open market transactions. Each share amount and weighted average per share sale price from August 25, 2005 through September 16, 2025 reflects the 1-for-20 reverse stock split of Vor Biopharma Inc. Common Stock effected September 18, 2025. 1. 19,367 shares on August 25, 2025, at a weighted average per share sale price of $42,3256. 2. 14,209 shares on August 26, 2025, at a weighted average per share sale price of $41.6165. 3. 30,582 shares on August 27, 2025, at a weighted average per share sale price of $40.1057. 4. 40,317 shares on August 28, 2025, at a weighted average per share sale price of $40.2307. 5. 27,730 shares on September 3, 2025, at a weighted average per share sale price of $39.9222. 6. 22,650 shares on September 4, 2025, at a weighted average per share sale price of $38.5709. 7. 20,000 shares on September 5, 2025, at a weighted average per share sale price of $39.3639. 8. 23,221 shares on September 8, 2025, at a weighted average per share sale price of $39.7949. 9. 22,461 shares on September 9, 2025, at a weighted average per share sale price of $40,0084. 10. 17,500 shares on September 10, 2025, at a weighted average per share sale price of $36.3019. 11. 14,240 shares on September 11, 2025, at a weighted average per share sale price of $36.6151. 12. 15,000 shares on September 12, 2025, at a weighted average per share sale price of $35.0811. 13. 20,000 shares on September 15, 2025, at a weighted average per share sale price of $32.815. 14. 22,363 shares on September 16, 2025, at a weighted average per share sale price of $30.8023. 15. 1,400 shares on October 1, 2025, at a weighted average per share sale price of $39.1925. 16. 32,451 shares on October 2, 2025, at a weighted average per share sale price of $39.828. 17. 7,901 shares on October 3, 2025, at a weighted average per share sale price of $37.832. 18. 70,763 shares on October 6, 2025, at a weighted average per share sale price of $37.0079. 19. 27,624 shares on October 7, 2025, at a weighted average per share sale price of $33.8369. 20. 75,262 shares on October 8, 2025, at a weighted average per share sale price of $33.8651. 21. 48,884 shares on October 9, 2025, at a weighted average per share sale price of $32.068. 22. 40,983 shares on October 10, 2025, at a weighted average per share sale price of $30.9673. 23. 22,006 shares on October 13, 2025, at a weighted average per share sale price of $32.436. 24 33,668 shares on October 14, 2025, at a weighted average per share sale price of $30.3192.
Not applicable.
Not applicable.
Not applicable.